Use of behavioral economics and social psychology to improve treatment of acute respiratory infections (BEARI): rationale and design of a cluster randomized controlled trial [1RC4AG039115-01] - study protocol and baseline practice and provider characteristics

BMC Infectious Diseases

Jason N Doctor¹  Tara K Knight¹  Parth D Shah⁵  Noah J Goldstein²  Craig R Fox²  Jeffrey A Linder³  Daniella Meeker⁷  Mark W Friedberg⁴  Stephen D Persell⁶ 

[1] Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, 3335 S. Figueroa Street, Unit A, Los Angeles, CA 90089-7273, USA;Department of Psychology, UCLA Anderson School of Management, David Geffen School of Medicine at UCLA, 110 Westwood Plaza D-511, Los Angeles, CA 90095, USA;Division of General Medicine and Primary Care, Brigham and Women’s Hospital; Harvard Medical School, Boston, MA 02116, USA;RAND, 20 Park Plaza, Suite 920, Boston, MA 02116, USA;Department of Health Behavior, UNC Gillings School of Global Public Health, 308 Rosenau Hall, Campus Box 7440, Chapel Hill, NC 27599-7440, USA;Division of General Internal Medicine and Geriatrics, Institute for Healthcare Studies, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, 10th Floor, 60611, Chicago, IL, USA;RAND, 1776 Main St., Santa Monica, CA 9040, USA

关键词: Clinical decision support;    Social psychology;    Behavioral economics;    Acute respiratory infections;    Antibiotics;   

Others  :  1147514
DOI  :  10.1186/1471-2334-13-290

 received in 2013-06-04, accepted in 2013-06-20,  发布年份 2013

【 摘 要 】

Background

Inappropriate antibiotic prescribing for nonbacterial infections leads to increases in the costs of care, antibiotic resistance among bacteria, and adverse drug events. Acute respiratory infections (ARIs) are the most common reason for inappropriate antibiotic use. Most prior efforts to decrease inappropriate antibiotic prescribing for ARIs (e.g., educational or informational interventions) have relied on the implicit assumption that clinicians inappropriately prescribe antibiotics because they are unaware of guideline recommendations for ARIs. If lack of guideline awareness is not the reason for inappropriate prescribing, educational interventions may have limited impact on prescribing rates. Instead, interventions that apply social psychological and behavioral economic principles may be more effective in deterring inappropriate antibiotic prescribing for ARIs by well-informed clinicians.

Methods/design

The Application of Behavioral Economics to Improve the Treatment of Acute Respiratory Infections (BEARI) Trial is a multisite, cluster-randomized controlled trial with practice as the unit of randomization. The primary aim is to test the ability of three interventions based on behavioral economic principles to reduce the rate of inappropriate antibiotic prescribing for ARIs. We randomized practices in a 2 × 2 × 2 factorial design to receive up to three interventions for non-antibiotic-appropriate diagnoses: 1) Accountable Justifications: When prescribing an antibiotic for an ARI, clinicians are prompted to record an explicit justification that appears in the patient electronic health record; 2) Suggested Alternatives: Through computerized clinical decision support, clinicians prescribing an antibiotic for an ARI receive a list of non-antibiotic treatment choices (including prescription options) prior to completing the antibiotic prescription; and 3) Peer Comparison: Each provider’s rate of inappropriate antibiotic prescribing relative to top-performing peers is reported back to the provider periodically by email. We enrolled 269 clinicians (practicing attending physicians or advanced practice nurses) in 49 participating clinic sites and collected baseline data. The primary outcome is the antibiotic prescribing rate for office visits with non-antibiotic-appropriate ARI diagnoses. Secondary outcomes will examine antibiotic prescribing more broadly. The 18-month intervention period will be followed by a one year follow-up period to measure persistence of effects after interventions cease.

Discussion

The ongoing BEARI Trial will evaluate the effectiveness of behavioral economic strategies in reducing inappropriate prescribing of antibiotics.

Trials registration

ClinicalTrials.gov: NCT01454947

【 授权许可】

   
2013 Persell et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Grijalva CG, Nuorti JP, Griffin MR: Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009, 302:758-766.
• [2]Gonzales R, Malone DC, Maselli JH, Sande MA: Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001, 33:757-762.
• [3]Shehab N, Patel PR, Srinivasan A, Budnitz DS: Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008, 47:735-743.
• [4]Arias CA, Murray BE: Antibiotic-resistant bugs in the 21st century—a clinical super-challenge. N Engl J Med 2009, 360:439-443.
• [5]Klevens RM, Morrison MA, Nadle J, et al.: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
• [6]Ranji SR, Steinman MA, Shojania KG, Sundaram V, Lewis R, Arnold S, Gonzales R, Antibiotic Prescribing Behavior: Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies. In Technical Review 9 (Prepared by the Stanford University-UCSF Evidence-based Practice Center under Contract No. 290-02-0017). AHRQ Publication No. 04(06)-0051-4. Edited by Shojania KG, McDonald KM, Wachter RM, Owens DK. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
• [7]Linder JA: Antibiotic Prescribing for acute respiratory infections--success that’s way off the mark: comment on “A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis”. JAMA Intern Med 2013, 173:273-275.
• [8]Simon HA: Models of Man. New York: Wiley; 1957.
• [9]Gigerenzer G, Selten R (Eds): Bounded rationality: The adaptive toolbox. Cambridge, MA: MIT Press; 2001.
• [10]Ariely D: Predictably irrational: The hidden forces that shape our decisions. New York: HarperCollins; 2008.
• [11]DellaVigna S: Psychology and economics: evidence from the field. J Econ Lit 2009, 47:315-372.
• [12]Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH: Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis, Infectious Diseases Society of America. Clin Infect Dis 2002, 35:113-125.
• [13]Shulman ST, Bisno AL, Clegg HW, et al.: Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012, 55:1279-1282.
• [14]Irwin RS, Baumann MH, Bolser DC, et al.: Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(1 Suppl):1S-23S.
• [15]Mandell LA, Wunderink RG, Anzueto A, et al.: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
• [16]Cooper RJ, Hoffman JR, Bartlett JG, et al.: Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001, 134:509-517.
• [17]Gonzales R, Bartlett JG, Besser RE, et al.: Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001, 134:521-529.
• [18]Snow V, Mottur-Pilson C, Gonzales R: Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001, 134:518-520.
• [19]Arroll B, Kenealy T: Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 2005., 3CD000247
• [20]Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Emerg Med 2001, 37:698-702.
• [21]Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Emerg Med 2001, 37:703-710.
• [22]Lerner JS, Tetlock PE: Accounting for the effects of accountability. Psychol Bull 1999, 125:255-275.
• [23]Tetlock PE, Skitka L, Boettger R: Social and cognitive strategies for coping with accountability: conformity, complexity, and bolstering. J Pers Soc Psychol 1989, 57:632-640.
• [24]Sedikides C, Herbst KC, Hardin DP, Dardis GJ: Accountability as a deterrent to self-enhancement: the search for mechanisms. J Pers Soc Psychol 2002, 83(3):592-605.
• [25]Johnson EJ, Goldstein D: Do defaults save lives? Science 2003, 302:1338-1339.
• [26]Thaler RH, Sunstein CR: Nudge: Improving decisions about health, wealth, and happiness. New Haven: Yale University Press; 2008.
• [27]Madrian BC, Shea DF: The power of suggestion: Inertia in 401(k) participation and savings behavior. Q J Econ 2001, 116:1149-1187.
• [28]Thaler RH, Benartzi S: Save more tomorrow™: using behavioral economics to increase employee saving. J Polit Econ 2004, 112:S164-S187.
• [29]Macfarlane J, Holmes W, Macfarlane R, Britten N: Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 1997, 315:1211-1214.
• [30]Tversky A, Kahneman D: Availability: a heuristic for judging frequency and probability. Cogn Psychol 1973, 5:207-232.
• [31]Cialdini RB, Reno RR, Kallgren CA: A focus theory of normative conduct: recycling the concept of norms to reduce littering in public places. J Pers Soc Psychol 1990, 58:1015.
• [32]Cialdini RB: Influence: Science and practice. 5th edition. Boston: Allyn & Bacon; 2008.
• [33]Gerber AS, Rogers T: Descriptive social norms and motivation to vote: everybody’s voting and so should you. J Polit 2009, 71:178-191.
• [34]Goldstein NJ, Cialdini RB, Griskevicius V: A room with a viewpoint: using social norms to motivate environmental conservation in hotels. J Consum Res 2008, 35:472-482.
• [35]Marshall MN, Shekelle PG, Leatherman S, Brook RH: The public release of performance data: what do we expect to gain? A review of the evidence. JAMA 2000, 283:1866-1874.
• [36]Robinowitz DL, Dudley RA: Public reporting of provider performance: can its impact be made greater? Annu Rev Public Health 2006, 27:517-536.
• [37]Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW: Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001, 285:2871-2879.
• [38]Schultz PW, Nolan JM, Cialdini RB, Goldstein NJ, Griskevicius V: The constructive, destructive, and reconstructive power of social norms. Psychol Sci 2007, 18:429-434.
• [39]Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kehoe L: Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract 1999, 16:495-500.
• [40]O’Connell DL, Henry D, Tomlins R: Randomised controlled trial of effect of feedback on general practitioners’ prescribing in Australia. BMJ 1999, 318:507-511.
• [41]Sondergaard J, Andersen M, Stovring H, Kragstrup J: Mailed prescriber feedback in addition to a clinical guideline has no impact: a randomised, controlled trial. Scand J Prim Health Care 2003, 21:47-51.
• [42]Linder JA, Schnipper JL, Tsurikova R, et al.: Electronic health record feedback to improve antibiotic prescribing for acute respiratory infections. Am J Manag Care 2011, 16(12):311-319.
• [43]Ihaka R, Gentleman RR: A language for data analysis and graphics. J Comput Graph Stat 1996, 5:299-314.
• [44]Kish L: Survey Sampling. New York: John Wiley and Sons; 1965.